Alera Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$217K Buy
+7,497
New +$219K 0.03% 259
2024
Q1
Sell
-16,212
Closed -$467K 176
2023
Q4
$467K Sell
16,212
-165
-1% -$4.99K 0.06% 121
2023
Q3
$543K Sell
16,377
-1,408
-8% -$49.8K 0.09% 104
2023
Q2
$652K Buy
17,785
+2,754
+18% +$107K 0.14% 90
2023
Q1
$613K Sell
15,031
-306
-2% -$13.2K 0.14% 90
2022
Q4
$786K Buy
15,337
+569
+4% +$27.3K 0.19% 61
2022
Q3
$645K Sell
14,768
-4,636
-24% -$225K 0.18% 77
2022
Q2
$1.02M Sell
19,404
-1,814
-9% -$92.4K 0.28% 44
2022
Q1
$1.1M Buy
21,218
+13,793
+186% +$716K 0.25% 47
2021
Q4
$438K Buy
7,425
+24
+0.3% +$1.19K 0.12% 58
2021
Q3
$318K Buy
7,401
+393
+6% +$17.4K 0.09% 74
2021
Q2
$274K Buy
7,008
+326
+5% +$12.7K 0.08% 81
2021
Q1
$242K Sell
6,682
-59
-0.9% -$2.1K 0.08% 81
2020
Q4
$248K Sell
6,741
-599
-8% -$22K 0.09% 76
2020
Q3
$256K Sell
7,340
-496
-6% -$17.4K 0.1% 67
2020
Q2
$243K Buy
7,836
+812
+12% +$27.6K 0.13% 66
2020
Q1
$218K Buy
7,024
+217
+3% +$7.39K 0.13% 59
2019
Q4
$253K Sell
6,807
-1,179
-15% -$42K 0.12% 51
2019
Q3
$272K Sell
7,986
-1,043
-12% -$37.9K 0.13% 59
2019
Q2
$371K Buy
9,029
+293
+3% +$11.6K 0.19% 45
2019
Q1
$352K Sell
8,736
-1,777
-17% -$71.2K 0.17% 48
2018
Q4
$435K Buy
+10,513
New +$436K 0.27% 46

Other funds holding PFE

Alera Investment Advisors's PFE Position: Q3 2024 in Review

Alera Investment Advisors opened a new position in Pfizer (PFE) in Q3 2024: 7,497 shares worth $217K. The stake represents 0.03% of the portfolio and ranks #259 among its holdings. This is a return to the name: Alera Investment Advisors previously reported a position in PFE as recently as Q4 2023.

Alera Investment Advisors first reported a position in PFE in Q4 2018 and has held it in 22 quarters since. The position peaked at $1.1M in Q1 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Alera Investment Advisors held 7,497 shares of Pfizer worth $217K as of Q3 2024.
  • Pfizer was a new Alera Investment Advisors position in Q3 2024.
  • Pfizer made up 0.03% of Alera Investment Advisors's portfolio in Q3 2024, its #259 holding.
  • Alera Investment Advisors first reported a position in Pfizer in Q4 2018 and has held it in 22 quarters since.
  • Alera Investment Advisors's Pfizer position peaked at $1.1M in Q1 2022.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.